Nemaura Medical Investor Presentation Deck

IM To address this, we developed a Non-invasive daily wear continuous Glucose sensor targeting: Clinical Market: Type 2 diabetes: >60 million people in Europe² Consumer market: Pre-diabetes and Obesity: >90 million people¹ in USA [This market is currently deemed to be the largest opportunity for Nemaura]

View entire presentation